Edition:
United States

Biomerieux SA (BIOX.PA)

BIOX.PA on Paris Stock Exchange

73.30EUR
6:35am EDT
Change (% chg)

€-4.10 (-5.30%)
Prev Close
€77.40
Open
€77.50
Day's High
€77.80
Day's Low
€72.60
Volume
73,943
Avg. Vol
124,395
52-wk High
€82.20
52-wk Low
€59.00

Chart for

About

Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial... (more)

Overall

Beta: 0.35
Market Cap(Mil.): €9,161.16
Shares Outstanding(Mil.): 118.36
Dividend: 0.34
Yield (%): 0.44

Financials

  BIOX.PA Industry Sector
P/E (TTM): 38.39 41.57 33.15
EPS (TTM): 2.02 -- --
ROI: 10.33 14.53 13.23
ROE: 14.19 17.68 15.27

BRIEF-Biomerieux Q1 Sales Up 3.4 Percent 587 Million Euros

* NET DEBT AMOUNTED TO EUR 84 MILLION AT MARCH 31, 2018, VERSUS EUR 156 MILLION AT DECEMBER 31, 2017

Apr 19 2018

BRIEF-Biomerieux Acquires Astute Medical Inc. For About $90 Mln In Cash

* ANNOUNCED ON WEDNESDAY, ACQUISITION OF ASTUTE MEDICAL INC FOR ABOUT $90 MLN IN CASH

Apr 05 2018

French and Benelux stocks-Factors to watch on April 5

April 5 Below are company-related news and stories from French and Benelux media which could have an impact on the region's markets or individual stocks.

Apr 05 2018

BRIEF-Biomerieux FY Sales Up At 2.29 Billion Euros

* FY OPERATING INCOME EUR 315 MILLION VERSUS EUR 282 MILLION YEAR AGO

Feb 28 2018

BRIEF-Biomerieux FY ‍Sales Rise 10.2 Pct To EUR 2,288 Million

* ‍SALES MOMENTUM IN 2017 WITH 10.2% GROWTH IN SALES TO EUR 2,288 MILLION IN SALES​

Jan 23 2018

Earnings vs. Estimates